Royal Bank Of Canada reaffirmed their sector perform rating on shares of IMI (LON:IMI – Free Report) in a research note published on Friday morning,London Stock Exchange reports. Royal Bank Of Canada currently has a GBX 2,850 target price on the stock.
IMI has been the topic of a number of other reports. JPMorgan Chase & Co. upped their price objective on IMI from GBX 3,050 to GBX 3,300 and gave the company an “overweight” rating in a report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 3,250 target price on shares of IMI in a report on Wednesday, May 13th. Finally, Jefferies Financial Group restated a “buy” rating and issued a GBX 3,380 price target on shares of IMI in a research note on Friday. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, IMI currently has an average rating of “Moderate Buy” and a consensus target price of GBX 3,073.33.
View Our Latest Stock Report on IMI
IMI Price Performance
IMI (LON:IMI – Get Free Report) last announced its earnings results on Friday, July 31st. The company reported GBX 63.40 earnings per share for the quarter. IMI had a return on equity of 32.41% and a net margin of 14.09%. Equities research analysts expect that IMI will post 137.9737609 EPS for the current year.
IMI Company Profile
IMI is a global leader in fluid and motion control, engineering bespoke solutions that enhance safety, productivity and sustainability across critical industries in energy, automation and healthcare. We work in close partnership with customers to design, build and service high-performance valves, actuators and control systems that solve complex engineering challenges.
Our solutions are a small part of our customers’ systems – but they play a critical role in how those systems perform. By combining deep technical expertise with real customer insight, we deliver solutions that are precisely engineered for impact.
Through our One IMI model, we combine commercial excellence, market-led innovation and continuous improvement to scale what works across the business.
Further Reading
- Five stocks we like better than IMI
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.
